Tiefeng F. Shi

246 Xuefu Road
Harbin, 150001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Retraction notice to "Investigating the mechanism of METTL16-dependent m6A modification regulating the SAMD11 protein signaling pathway to inhibit thyroid cancer phenotypes" [Int. J. Biol. Macromol. 280 (2024) 136176].

Retraction notice to "Investigating the mechanism of METTL16-dependent m6A modification regulating the SAMD11 protein signaling pathway to inhibit thyroid cancer phenotypes" [Int. J. Biol. Macromol. 280 (2024) 136176].

Journal: International journal of biological macromolecules

Published: July 29, 2026

Prediction of Central Lymph Node Metastasis in Papillary Thyroid Carcinoma Using Multi-Ultrasound Radiomics of Intratumoral and Peritumoral Regions.

Prediction of Central Lymph Node Metastasis in Papillary Thyroid Carcinoma Using Multi-Ultrasound Radiomics of Intratumoral and Peritumoral Regions.

Journal: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine

Published: November 11, 2025

APOL1 is a novel prognostic biomarker in thyroid cancer and correlates with immune infiltration.

APOL1 is a novel prognostic biomarker in thyroid cancer and correlates with immune infiltration.

Journal: Frontiers in oncology

Published: September 17, 2025

METTL3-mediated m6A modification of TACSTD2 mRNA inhibits papillary thyroid cancer progression by activating the TNF signaling and blocking epithelial-mesenchymal transition.

METTL3-mediated m6A modification of TACSTD2 mRNA inhibits papillary thyroid cancer progression by activating the TNF signaling and blocking epithelial-mesenchymal transition.

Journal: Scientific reports

Published: July 13, 2025

Clinical effect analysis of endoscopic radical thyroidectomy via three-port gasless intermuscular approach

Clinical effect analysis of endoscopic radical thyroidectomy via three-port gasless intermuscular approach

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: March 09, 2025

Circular RNA 14580 promotes papillary thyroid cancer progression by interacting with CTSW/fibrosis singling pathway.

Circular RNA 14580 promotes papillary thyroid cancer progression by interacting with CTSW/fibrosis singling pathway.

Journal: International journal of biological macromolecules

Published: September 05, 2024

Contrast-enhanced ultrasound combined with percutaneous ultrasound-guide core needle biopsies in the diagnosis of pancreatic lesions: a propensity score-matched study.

Contrast-enhanced ultrasound combined with percutaneous ultrasound-guide core needle biopsies in the diagnosis of pancreatic lesions: a propensity score-matched study.

Journal: BMC cancer

Published: August 20, 2024

Investigating the mechanism of METTL16-dependent m6A modification regulating the SAMD11 protein signaling pathway to inhibit thyroid cancer phenotypes.

Investigating the mechanism of METTL16-dependent m6A modification regulating the SAMD11 protein signaling pathway to inhibit thyroid cancer phenotypes.

Journal: International journal of biological macromolecules

Published: August 01, 2024

Identification of Potential Biomarkers in Papillary Thyroid Carcinoma Based on Proteomics.

Identification of Potential Biomarkers in Papillary Thyroid Carcinoma Based on Proteomics.

Journal: OncoTargets and therapy

Published: June 01, 2024

Ultrasound radiomics models based on multimodal imaging feature fusion of papillary thyroid carcinoma for predicting central lymph node metastasis.

Ultrasound radiomics models based on multimodal imaging feature fusion of papillary thyroid carcinoma for predicting central lymph node metastasis.

Journal: Frontiers in oncology

Published: July 18, 2023

The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2.

The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2.

Journal: Bioengineered

Published: February 25, 2022

BRAFV600E mutation, BRAF-activated long non-coding RNA and miR-9 expression in papillary thyroid carcinoma, and their association with clinicopathological features.

BRAFV600E mutation, BRAF-activated long non-coding RNA and miR-9 expression in papillary thyroid carcinoma, and their association with clinicopathological features.

Journal: World journal of surgical oncology

Published: April 30, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026